Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > FDA Approves Diabetes Drug Metformin For Anti-Aging Human ..
View:
Post by Scruggstyle on Dec 07, 2015 10:24pm

FDA Approves Diabetes Drug Metformin For Anti-Aging Human ..

FDA Approves Diabetes Drug Metformin For Anti-Aging Human Trials . . .

as per recent news releases around the world and also the feature of last week's episode of National Geographic's TV Series "Breakthrough".

https://news.nationalgeographic.com/2015/10/151028-ron-howard-science-aging-breakthrough-documentary/
-------------------------------------------------------------------------------------------------------------------------------

and FYI . . .

AMCo launches Metformin 500mg/5ml Oral Solution x 150ml for diabetes.

AMCo is delighted to announce the launch of Metformin Oral Solution. It will be launched by the Focus Pharma division of AMCo.  This product is indicated to treat type II diabetes, a fast growing health issue within the UK.

Comment by moneymotivator on Dec 07, 2015 11:37pm
Isnt that no so recent news? still though tks for sharing! 
Comment by Scruggstyle on Dec 08, 2015 12:26am
As far as I know it was just within the last two weeks.  Trials to start in 2016.
Comment by sunshine7 on Dec 08, 2015 10:07am
Reads like original approval was for UK or EU market. New approval from FDA (US market). This may be an example of expanded geographical marketing, a result of now being a global company. Look for more of this. 1+1= 3.
Comment by Scruggstyle on Dec 08, 2015 10:25am
I believe that this is a widely available drug that has been used to treat diabetes. The new study that just got approval by the FDA, is a first. It is not that AMCO has any exclusivity to this drug, but the thought that this trial may pave the way for humans to someday live 50+% longer, and that our company may be a player in the game, I thought to be interesting enough to post.
Comment by cashflow98 on Dec 08, 2015 10:47am
Thanks all. Scruggstyle great info...this drug is being used to treat type 2 diabetes currently but may also become an anti-aging drug. Interesting read attached : https://www.endocrineweb.com/news/diabetes/18692-metformin-protection-against-alzheimers-cancer-heart-disease
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities